News05/10/2026
AstraZeneca completes Summit Therapeutics equity investment
AstraZeneca PLC →AstraZeneca announced completion of its equity investment in Summit Therapeutics. The associated clinical collaborations are intended to evaluate combinations with AstraZeneca antibody-drug conjugates; no efficacy outcome is implied.